Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

toripalimab × Breast × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5 Gastrointestinal 5 Thoracic 4 Genitourinary 3 Gynecologic 2 Tumor-Agnostic 1 Other solid neoplasm 1 Dermatologic 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Letrozole 39 Paclitaxel 37 Fulvestrant 37 pembrolizumab 33 Specimen Handling 32 Magnetic Resonance Spectroscopy 29 Trastuzumab 28 Capecitabine 23 Anastrozole 22 ribociclib 21 Biopsy 21 exemestane 19 Tamoxifen 18 Carboplatin 18 Cyclophosphamide 17 trastuzumab deruxtecan 16 pertuzumab 16 abemaciclib 15 palbociclib 14 Docetaxel 14 Blood Specimen Collection 14 130-nm albumin-bound paclitaxel 14 Taxes 12 Radiotherapy 12 olaparib 11 Doxorubicin 11 inavolisib 10 eribulin 9 X-Rays 9 tucatinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07457359 2026-03-09

NEOTRIO-2

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡